Riel, Henrik
Vicenzino, Bill
Olesen, Jens Lykkegaard
Jensen, Martin Bach
Ehlers, Lars Holger
Rathleff, Michael Skovdal
Funding for this research was provided by:
Danmarks Frie Forskningsfond (7016-00044B)
Fonden for Almen Praksis (A1856)
Fonden for Faglig Udvikling af Speciallægepraksis (A1616)
Multipraksisundersøgelsesudvalget (EMN-2019-00711)
Article History
Received: 25 October 2019
Accepted: 9 December 2019
First Online: 2 January 2020
Ethics approval and consent to participate
: The trial is being conducted according to the Declaration of Helsinki III, and the protocol, template informed consent forms, and participant information were approved by the Ethics Committee of North Denmark Region (N-20180066) prior to the inclusion of participants. All participants provide informed consent before enrolment. When participants sign the consent form, they agree that they have been adequately informed about the purpose, methods, advantages, and disadvantages of participation; they know that participation is voluntary; and they can withdraw from the trial without losing their current or future rights to receive treatment.
: Not applicable.
: The authors declare that they have no competing interests.